Background. Vitiligo is an acquired disorder characterized by depigmented macules or patches on the skin due to the loss of functional melanocytes. Segmental vitiligo (SV) is a subtype of vitiligo refractory to treatment.
J Clin Aesthet Dermatol. 2019;12(11):28–31 by Sherine Hosny Ahmed Abdel Rahman, MD; Mohamed Saber Hussein, MD; and Amira Ibrahim Mansour, MD Drs. Ahmed, Hussein, and Mansour are with the Faculty of Medicine, Benha University in Banha, Egypt. FUNDING: No funding was provided for this study. DISCLOSURES: The authors have no conflicts of interest relevant to
Dear Editor: Public awareness of diseases has been shown to increased when celebrities publicly disclose their own.1–3 Hugh Jackman’s public disclosure of his basal cell carcinoma diagnoses via social media is an example in dermatology.4 Here, we evaluated current trends on vitiligo, with emphasis on two celebrities with the condition: the late “King of Pop,”
John A. Mouzakis, MD is from University of South Florida College of Medicine, Tampa, Florida. Stephanie Liu, MD and George Cohen, MD are from Department of Dermatology and Cutaneous Surgery, University of South Florida College of Medicine, Tampa, Florida
Jason J. Emer, MD; Claire Wolinsky, BS The Mount Sinai School of Medicine, Department of Dermatology, New York, New York Abstract The treatment of many dermatological disorders, such as autoimmune and immune-mediated diseases, consists of the use of systemic corticosteroids alone or in combination with other steroid-sparing immunosuppressants. Often, these treatment regimens are sufficient to